Mitchel Fromm

1.0k total citations · 1 hit paper
5 papers, 723 citations indexed

About

Mitchel Fromm is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Mitchel Fromm has authored 5 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Mitchel Fromm's work include Pancreatic and Hepatic Oncology Research (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Gastric Cancer Management and Outcomes (2 papers). Mitchel Fromm is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Gastric Cancer Management and Outcomes (2 papers). Mitchel Fromm collaborates with scholars based in United States. Mitchel Fromm's co-authors include Christopher G. Willett, Kathryn Winter, Howard Safran, John P. Hoffman, Michael G. Haddock, William F. Regine, André Konski, John S. Macdonald, Tyvin A. Rich and Ross A. Abrams and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Mitchel Fromm

5 papers receiving 710 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma

2008 527 citations William F. Regine, Kathryn Winter et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mitchel Fromm United States	4	552	355	307	191	167	5	723
J. Furuse Japan	13	384 0.7×	231 0.7×	281 0.9×	205 1.1×	108 0.6×	40	708
Iwao Ozawa Japan	12	525 1.0×	289 0.8×	313 1.0×	178 0.9×	95 0.6×	49	641
Catherine Jephcott United Kingdom	7	321 0.6×	165 0.5×	166 0.5×	120 0.6×	121 0.7×	10	443
C. Kourousis Greece	13	445 0.8×	354 1.0×	188 0.6×	60 0.3×	72 0.4×	20	641
Iris Gluck Israel	15	634 1.1×	307 0.9×	303 1.0×	90 0.5×	90 0.5×	26	1.0k
Thomas O’Rourke Australia	6	649 1.2×	245 0.7×	431 1.4×	42 0.2×	61 0.4×	9	904
Georgios Gemenetzis United States	17	1.2k 2.2×	550 1.5×	479 1.6×	297 1.6×	501 3.0×	37	1.3k
David L. Sherr United States	11	347 0.6×	143 0.4×	160 0.5×	96 0.5×	106 0.6×	22	682
B. Sischy United States	14	451 0.8×	394 1.1×	597 1.9×	84 0.4×	125 0.7×	24	856
Graciela R. Garton United States	11	232 0.4×	289 0.8×	193 0.6×	146 0.8×	72 0.4×	14	633

Countries citing papers authored by Mitchel Fromm

Since Specialization

Citations

This map shows the geographic impact of Mitchel Fromm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchel Fromm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchel Fromm more than expected).

Fields of papers citing papers by Mitchel Fromm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchel Fromm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchel Fromm. The network helps show where Mitchel Fromm may publish in the future.

Co-authorship network of co-authors of Mitchel Fromm

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchel Fromm. A scholar is included among the top collaborators of Mitchel Fromm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchel Fromm. Mitchel Fromm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Chen, Yan, et al.. (2021). Comparing Collapsed Cone Convolution Algorithm With Acuros and Its Implication on NRG Clinical Trials. International Journal of Radiation Oncology*Biology*Physics. 111(3). e146–e146. 1 indexed citations

2.

Ben‐Josef, Edgar, William F. Regine, Ross A. Abrams, et al.. (2015). Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas. Clinical Cancer Research. 21(24). 5612–5618. 5 indexed citations

3.

Regine, William F., Kathryn Winter, Ross A. Abrams, et al.. (2008). Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma. JAMA. 299(9). 1019–1019. 527 indexed citations breakdown →

4.

Ajani, Jaffer A., Kathryn Winter, Ritsuko Komaki, et al.. (2008). Phase II Randomized Trial of Two Nonoperative Regimens of Induction Chemotherapy Followed by Chemoradiation in Patients With Localized Carcinoma of the Esophagus: RTOG 0113. Journal of Clinical Oncology. 26(28). 4551–4556. 90 indexed citations

5.

Fromm, Mitchel, Philip Littman, R. Beverly Raney, et al.. (1986). Late effects after treatment of twenty children with soft tissue sarcomas of the head and neck. Experience at a single institution with a review of the literature. Cancer. 57(10). 2070–2076. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact